Vincerx Pharma Inc VINC:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/24/21 EST
20.27quote price arrow up+1.03 (+5.35%)
Volume
208,774
52 week range
9.35 - 22.94

...

Loading . . .

KEY STATS

  • Open19.45
  • Day High20.27
  • Day Low19.00
  • Prev Close20.27
  • 52 Week High22.94
  • 52 Week High Date01/07/21
  • 52 Week Low9.35
  • 52 Week Low Date05/27/20
  • Market Cap283.37M
  • Shares Out13.98M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.07
  • P/E (TTM)-288.75
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-173,000.00
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)1.60%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Vincerx Pharma Inc News

There is no recent news for this security.

Latest VINC News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Vincerx Pharma, Inc., formerly Vincera Pharma, Inc., is a clinical-stage life sciences company. The Company focuses on the development and oncology knowledge to advance new therapies for the treatment of cancer. The Company’s small molecule drug program includes VIP152, a clinical-stage positive transcription elongation factor beta/cyclin-dependent kinase 9 (PTEFb/CDK9) inhibitor. Its antibody-drug conjugate (ADC) platform includes VIP943 (targeting CD123) and VIP924...
Address
260 Sheridan Avenue, Suite 400
Palo Alto, CA
94306
United States